What is Estrella Immunopharma, Inc. Common Stock's Market Cap?

Estrella Immunopharma, Inc. Common Stock's Market Cap is $27.1M, based on as-reported figures from SEC (XBRL) filings.

What is Estrella Immunopharma, Inc. Common Stock's Enterprise Value?

Estrella Immunopharma, Inc. Common Stock's Enterprise Value is $25.2M, based on as-reported figures from SEC (XBRL) filings.

What is Estrella Immunopharma, Inc. Common Stock's Net Income (TTM)?

Estrella Immunopharma, Inc. Common Stock's Net Income (TTM) is -$13.3M, based on as-reported figures from SEC (XBRL) filings.

What is Estrella Immunopharma, Inc. Common Stock's Diluted EPS (TTM)?

Estrella Immunopharma, Inc. Common Stock's Diluted EPS (TTM) is -0.30, based on as-reported figures from SEC (XBRL) filings.

What is Estrella Immunopharma, Inc. Common Stock's Net Debt?

Estrella Immunopharma, Inc. Common Stock's Net Debt is -$1.9M, based on as-reported figures from SEC (XBRL) filings.

Estrella Immunopharma, Inc. Common Stock (ESLA) Financial Statements

Estrella Immunopharma, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00ZDR7G14

XNAS · usd

0.62▼ 0.02 (-2.55%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.64

Day's Range0.62 – 0.72

52-Week Range0.59 – 3.15

Volume53.3K

Avg Volume28.7K

Share Statistics

Shares Outstanding

Employees—

ExchangeXNAS

Listed2023-10-02

Share count as of August 11, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Estrella Immunopharma, Inc. Common Stock (ESLA)

What is Estrella Immunopharma, Inc. Common Stock's Market Cap?: Estrella Immunopharma, Inc. Common Stock's Market Cap is $27.1M, based on as-reported figures from SEC (XBRL) filings.
What is Estrella Immunopharma, Inc. Common Stock's Enterprise Value?: Estrella Immunopharma, Inc. Common Stock's Enterprise Value is $25.2M, based on as-reported figures from SEC (XBRL) filings.
What is Estrella Immunopharma, Inc. Common Stock's Net Income (TTM)?: Estrella Immunopharma, Inc. Common Stock's Net Income (TTM) is -$13.3M, based on as-reported figures from SEC (XBRL) filings.
What is Estrella Immunopharma, Inc. Common Stock's Diluted EPS (TTM)?: Estrella Immunopharma, Inc. Common Stock's Diluted EPS (TTM) is -0.30, based on as-reported figures from SEC (XBRL) filings.
What is Estrella Immunopharma, Inc. Common Stock's Net Debt?: Estrella Immunopharma, Inc. Common Stock's Net Debt is -$1.9M, based on as-reported figures from SEC (XBRL) filings.